Peroxisome proliferator-activated receptor gamma transactivation-mediated potentiation of glucose uptake by Bai-Hu-Tang

Journal of Ethnopharmacology

Volumn 118, Issue 1, 2008, Pages 46-50

  Chen, Ching Chu ^a,b   Hsiang, Chien Yun ^c   Chiang, An Na ^d   Lo, Hsin Yi ^a   Li, Chia Ing ^a  

^a CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b School of Chinese Medicine   (Taiwan)

^c CHINA MEDICAL UNIVERSITY   (Taiwan)

^d NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

3T3 L1 adipocyte; Bai Hu Tang; Glucose uptake; Herbs; PPAR

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; BAI HU TANG; CALCIUM SULFATE; CALPASTATIN; GLUCOSE; HERBACEOUS AGENT; INSULIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PHOSPHATIDYLINOSITOL 3 KINASE;

ANEMARRHENA; ANIMAL CELL; ARTICLE; CELL STRAIN 3T3; CONTROLLED STUDY; ENZYME ACTIVATION; GLUCOSE TRANSPORT; GLYCYRRHIZA; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PROTEIN EXPRESSION; RICE; SIGNAL TRANSDUCTION; TRANSACTIVATION; WESTERN BLOTTING;

3T3-L1 CELLS; ADIPOCYTES; ANEMARRHENA; ANIMALS; BLOTTING, WESTERN; CALCIUM SULFATE; CELL LINE, TUMOR; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUGS, CHINESE HERBAL; GLUCOSE; GLYCYRRHIZA; HUMANS; INSULIN; LIVER NEOPLASMS; MEDICINE, CHINESE TRADITIONAL; MICE; ORYZA SATIVA; PPAR GAMMA; SIGNAL TRANSDUCTION;

ANEMARRHENA; GLYCYRRHIZA;

EID: 44149088783     PISSN: 03788741     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jep.2008.03.001     Document Type: Article

References (20)

1. Beck-Nielsen H., Vaag A., Damsbo P., Handberg A., Nielsen O.H., Henriksen J.E., and Thye-Ronn P. Insulin resistance in skeletal muscles in patients with NIDDM. Diabetes Care 15 (1992) 418-429
2. 3 kinase pathway. Life Sciences 75 (2004) 2653-2664
3. Desvergne B., and Wahli W. Peroxisome proliferators-activated receptor: nuclear control of metabolism. Endocrine Reviews 20 (1999) 649-688
4. Green H., and Meuth M. An established pre-adipose cell line and its differentiation in culture. Cell 3 (1974) 127-133
5. Kamei R., Kitagawa Y., Kadokura M., Hattori F., Hazeki O., Ebina Y., Nishihara T., and Oikawa S. Shikonin stimulates glucose uptake in 3T3-L1 adipocytes via an insulin-independent tyrosine kinase pathway. Biochemical and Biophysical Research Communications 292 (2002) 642-651
6. y mice. Phytotherapy Research 13 (1999) 484-488
7. Leahy J.L., Bonner-Weir S., and Weir G.C. β-Cell dysfunction induced by chronic hyperglycemia: current ideals on mechanism of impaired glucose-induced insulin secretion. Diabetes Care 15 (1992) 442-455
8. Oubre A.Y., Carlson T.J., King S.R., and Reaven G.M. From plant to patient: an ethnomedical approach to the identification of new drug for the treatment of NIDDM. Diabetologia 40 (1997) 614-617
9. Reginato M.J., Krakow S.L., Bailey S.T., and Lazar M.A. Prostaglandins promote and block adipogenesis through opposing effects on peroxisome proliferator-activated receptor gamma. The Journal of Biological Chemistry 273 (1998) 1855-1858
10. Rosen E.D., and Spiegelman B.M. PPARγ: a nuclear regulator of metabolism, differentiation, and cell growth. The Journal of Biological Chemistry 276 (2001) 377311-377314
11. Saad M.F., Knowler W.G., Pettitt D.J., Nelson R.G., Mott D.M., and Bennett P.H. The natural history of impaired glucose tolerance in the Pima Indians. New England Journal of Medicine 319 (1988) 1500-1506
12. Saltiel A.R., and Kahn C.R. Insulin signaling and the regulation of glucose and lipid metabolism. Nature 414 (2001) 799-806
13. Schopfer F.J., Lin Y., Baker P.R., Cui T., Garcia-Barrio M., Zhang J., Chen K., Chen Y.E., and Freeman B.A. Nitrolinoleic acid: an endogenous peroxisome proliferator-activated receptor gamma ligand. Proceeding of the National Academy of Sciences of the United States of America, vol. 102 (2005) 2340-2345
14. Taylor S.I., Accili D., and Imai Y. Insulin resistance or insulin deficiency which is the primary cause of NIDDM?. Diabetes 43 (1994) 735-740
15. White M.F. IRS proteins and the common path to diabetes. American Journal of Physiology. Endocrinology and Metabolism 283 (2002) E413-E422
16. Xu M.E., Xiao S.Z., Sun Y.H., Zheng X.X., Yang O.Y., and Chen G. The study of anti-metabolic syndrome effect of puerarin in vitro. Life Sciences 77 (2005) 3183-3196
17. Yang Y., Shang W., Zhou L., Jiang B., Jin H., and Chen M. Emodin with PPARγligand-binding activity promotes adipocyte differentiation and increases glucose uptake in 3T3-L1 cells. Biochemical and Biophysical Research Communications 353 (2007) 2225-2230
18. Yeh G.Y., Kaptchuk T.J., Eisenberg D.M., and Philips R.S. Systematic review of herbs and dietary supplements for glycemic control in diabetes. Diabetes Care 26 (2003) 1277-1294
19. Young P.W., Cawthrone M.A., Coyle P.J., Holder J.C., Holman G.D., Kozka I.J., Kirkham D.M., Lister C.A., and Smith S.A. Repeat treatment of obese mice with BRL 49653 a new and potent insulin sensitizer, enhances insulin action in white adipocytes: association with increased insulin binding and cell-surface GLUT4 as measured by photoaffinity labeling. Diabetes 44 (1995) 1087-1092
20. Zierath J., and Wallberg-Henriksson H. From receptor to effector: insulin signal transduction in skeletal muscle from type II diabetic patients. Annals of the New York Academy of Sciences 967 (2002) 120-134